Biofrontera Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Biofrontera Inc. (BFRI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 31.34 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-13
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 18.90K shares, a 59.05% decline year-over-year.
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 12.44K shares, a 43.17% decline year-over-year.
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 69.22K shares, a 395.93% increase year-over-year.
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 54.58K shares, a 1034.78% increase year-over-year.
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 191.84K shares, a 524.45% increase from fiscal 2024.
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 30.72K shares, a 17.40% decline from fiscal 2023.
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 37.20K shares, a 345.02% increase from fiscal 2022.
- Biofrontera Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 8.36K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 18.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 31.34K shares 10-Q · filed 2026-08-13 | 100.56K shares derived: sum of 3 quarters · filed 2026-08-13 | 155.14K shares derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | 12.44K shares 10-Q · filed 2026-05-14 | 81.66K shares derived: sum of 2 quarters · filed 2026-05-14 | 136.24K shares derived: sum of 3 quarters · filed 2026-05-14 | 182.40K shares derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-12-31 | 69.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 123.81K shares derived: sum of 2 quarters · filed 2026-03-19 | 169.96K shares derived: sum of 3 quarters · filed 2026-03-19 | 191.84K shares 10-K · filed 2026-03-19 | |
| 2025-09-30 | 54.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 100.73K shares derived: sum of 2 quarters · filed 2025-11-12 | 122.62K shares 10-Q · filed 2025-11-12 | 136.58K shares derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-06-30 | 46.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 68.04K shares 10-Q · filed 2025-08-13 | 82.00K shares derived: sum of 3 quarters · filed 2026-03-19 | 86.81K shares derived: sum of 4 quarters · filed 2026-03-19 | |
| 2025-03-31 | 21.89K shares 10-Q · filed 2025-05-15 | 35.84K shares derived: sum of 2 quarters · filed 2026-03-19 | 40.66K shares derived: sum of 3 quarters · filed 2026-03-19 | 42.53K shares derived: sum of 4 quarters · filed 2026-03-19 | |
| 2024-12-31 | 13.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 18.77K shares derived: sum of 2 quarters · filed 2026-03-19 | 20.65K shares derived: sum of 3 quarters · filed 2026-03-19 | 30.72K shares 10-K · filed 2026-03-19 | |
| 2024-09-30 | 4.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 6.69K shares derived: sum of 2 quarters · filed 2024-11-14 | 16.76K shares 10-Q · filed 2024-11-14 | 22.48K shares derived: sum of 4 quarters · filed 2025-03-20 | |
| 2024-06-30 | 1.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 11.95K shares 10-Q · filed 2024-08-14 | 17.67K shares derived: sum of 3 quarters · filed 2025-03-20 | 28.73K shares derived: sum of 4 quarters · filed 2025-03-20 | |
| 2024-03-31 | 10.08K shares 10-Q · filed 2024-05-15 | 15.79K shares derived: sum of 2 quarters · filed 2025-03-20 | 26.85K shares derived: sum of 3 quarters · filed 2025-03-20 | -11.53K shares derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-12-31 | 5.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 16.78K shares derived: sum of 2 quarters · filed 2025-03-20 | -21.61K shares derived: sum of 3 quarters · filed 2025-03-20 | 37.20K shares 10-K · filed 2025-03-20 | |
| 2023-09-30 | 11.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -27.32K shares derived: sum of 2 quarters · filed 2023-11-09 | 31.48K shares 10-Q · filed 2023-11-09 | -63.91M shares derived: sum of 4 quarters · filed 2024-03-15 | |
| 2023-06-30 | -38.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 20.42K shares 10-Q · filed 2023-08-11 | -63.92M shares derived: sum of 3 quarters · filed 2024-03-15 | -63.92M shares derived: sum of 4 quarters · filed 2024-03-15 | |
| 2023-03-31 | 58.80K shares 10-Q · filed 2023-05-12 | -63.88M shares derived: sum of 2 quarters · filed 2024-03-15 | -63.88M shares derived: sum of 3 quarters · filed 2024-03-15 | -38.03M shares derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-12-31 | -63.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -63.94M shares derived: sum of 2 quarters · filed 2024-03-15 | -38.09M shares derived: sum of 3 quarters · filed 2024-03-15 | 8.36K shares 10-K · filed 2024-03-15 | 166.76K shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 25.85M shares derived: sum of 2 quarters · filed 2022-11-14 | 63.95M shares 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | 25.85M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 63.95M shares 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | 38.10M shares 10-Q · filed 2022-05-13 | ||||
| 2021-12-31 | 205.00 shares 8-K · filed 2023-10-03 | 4.08K shares 10-K · filed 2022-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |